The Board of directors manages the Foundation and ensure that its assets are devoted to the meet the objectives of the Foundation.
The Board adopts the regulations necessary for its own running and the running of the Foundation in general.
The Board establishes the budget for each accounting period and publishes an annual written report on its management. It approves the annual Balance Sheet and Profit and Loss Account.
President, PhD, Emeritus Professor, Pathology & Immunology, University of Geneva
The laboratory of Walter Reith has a long-standing interest in molecular and cellular immunology. Major themes of past research have included the genetic control and biological functions of Major Histocompatibility Complex class II (MHCII) mediated antigen presentation in humans and mice in the context of health and disease.
Current topics focus on the molecular and cellular mechanisms that regulate gene expression in specialized antigen presenting cells (APCs) – including B cells, various dendritic cell (DC) subsets and thymic epithelial cells – and the functions of these APCs in adaptive immune responses, the physiological processes that mediate the establishment and maintenance of immunological self-tolerance, and the pathological mechanisms that underpin the breakdown of immunological self-tolerance during the course of autoimmune diseases.
Phone: +41 79 250 3539
Address: Faculty of medicine
University of Geneva
1 rue Michel-Servet
MD PhD, Emeritus Professor, coordinator of Microbiology and Oncology
Jean-Pierre Kraehenbuhl is the Chief Executive Officer of HSeT. He is emeritus Professor at the University of Lausanne, and was affiliated member of the Swiss Institute of Cancer Research (ISREC). He used to work on mucosal immunity and vaccinology. He was a co-founder of EuroVacc, a Foundation active in the development of HIV vaccines, He is a member of EMBO. He was the co- founder of OraVax, Inc, now part of Sanofi Pasteur. He is co-leader of OCTAVE, the Online Collaborative Training of AIDS Vaccine Evaluation.
Phone: +41 21 692 5856
Address: HSeT Foundation
c/o Center of Immunity and Infection (CIIL)
Chemin des Boveresses 155
CH-1066 Epalinges, Switzerland
PhD. Innovation lab : vaccines Institut Pasteur, Paris France
Armelle Phalipon has lead the group working on adaptive immunity to Shigella infection and development of vaccine strategies in the Molecular Microbial Pathogenesis Unit directed by Professor Philippe Sansonetti (Institut Pasteur). With more than 15 years of experience working on Shigella, she has deciphered the targets and effectors of the humoral response to infection and discovered two novel molecular mechanisms of secretory IgA-mediated protection at mucosal surfaces. She is currently studying the direct targeting of cells of the adaptive immunity by Shigella virulence effectors and its consequence in term of induction of the adaptive immune response. Dr. Phalipon has a long-standing interest in combining fundamental and applied research, as exemplified by her participation in the development of dipsticks for diagnosis of shigellosis in emergency conditions based on the use of monoclonal antibodies, generated by her, for fundamental research purposes. In addition, in collaboration with Dr. Laurence Mulard (Chemistry of Biomolecules Unit, Institut Pasteur), she has developed an alternative approach to design subunit vaccines to Shigella infection, i.e. chemically defined glycoconjugate vaccines based on the use of synthetic oligosaccharides mimicking the protective epitopes of the polysaccharide moiety of lipopolysaccharide, the main protective Shigella antigen. A phase I trial will be started in 2016. Dr. Phalipon has been member of the WHO Steering Committee for Diarrheoal Diseases. Deeply involved since many years in teaching activities both at the national and international level, she launched in collaboration with Frédéric Tangy the first Vaccinology Course at the Pasteur Institute in 2008.
Address: Institut Pasteur
28 Rue du Dr. Roux
75724 Paris Cedex 15, France
MD, Associate Professor , Internal Medicine & Nephrology, Medical Faculty Bern University
Uyen Huynh-Do is Associate Professor of Internal Medicine and Nephrology at the Faculty of Medicine of the University of Bern. She was trained as an MD at the University of Zurich, then specialized in renal physiology and hypertension. From 1996 to 1999 Uyen Huynh-Do joined the Division of Nephrology and the Vanderbilt Center for Vascular Biology at Vanderbilt University Medical Center (Nashville, TN) as a Postdoctoral Research Fellow. In 2004 she was appointed Assistant Professor, and in 2008 Associate Professor at the University Hospital of Bern. In 2009 she received a Master of Medical Education (MME) from the University of Bern and the Department of Medical Education, University of Illinois at Chicago. She is the director of the interuniversitary PhD and Postdoctoral programme IKPP (Integrative Kidney Physiology and Pathophysiology) supported by both the Swiss National Science Foundation and the European Union (Marie Curie FP7 Co-Fund).
MD, MHPE, Vice Dean Medical education, Medical Faculty Geneva University
Mathieu Nendaz is an internist at the Geneva University Hospitals and trained in health professions education at the University of Illinois at Chicago. He is presently also Director of the Unit of Development and Research (UDREM) and Professor at the Faculty of Medicine, University of Geneva, Switzerland. His research interests include Internal Medicine and Medical Education. In this field, he is particularly interested in decision-making, clinical reasoning, clinical supervision, and interprofessional issues. He is deeply involved in direct teaching, clinical supervision and training, as well as in the development and organization of teaching concepts and medical curriculum.
MD, PhD, Emeritus Professor, Swiss Federal Institute of Technology
Trained as an MD, William F. Pralong did his Thesis in Transport Phenomena at the Dpt of Pharmacology, School of Medicine in Geneva. He specialized then in Diabetes and Pancreas Physiology. He moved to industry to work on artificial pancreas and then conducted clinical trials in genetherapy for EPO delivery at the Dept of Experimental Surgery with Patrick Aebischer at the CHUV, Lausanne. He joined EPFL in 2000 with EPFL’s President, Patrick Aebischer to set up the curriculum in Life Sciences and Technology and in Bioengineering at the School of Life Sciences. Presently William Pralong is Deputy to the Provost for MQS at the Swiss Federal Institute of Technology.
MD, FAMH Laboratory Medicine, coordinator HSeT
Michelle Rossier received an M.D. from the University of Lausanne (Switzerland) and completed a MD thesis medical Department of Physiology of the University of Geneva. After a postdoctoral research fellowship, she held an assistant research physiologist position at the Department of Physiology, University of California, San Francisco. She then returned to the Institute of Pharmacology at the University of Lausanne, where she became a « maître assistant ». From 1977 to 2006 she was Director of the clinical laboratories of Hematology, Clinical Chemistry and Microbiology at the Hospital of Morges, Switzerland. In 2001 she held the same position with Viollier Inc., one of the largest private clinical laboratories in Switzerland. She joined the HSeT core team in February 2006 to become a project coordinator for several HSeT projects.
PhD, Emeritus Professor, Faculty of Sciences, University of Geneva
Jean Gruenberg’s main interest was to study the morphogenesis of sub-cellular organelles and the mechanisms that control intracellular membrane dynamics. He is also a member of LipidX (Systems Biology of Biomembranes) supported by the Swiss Initiative in Systems Biology.
Phone: +41(0)22 37 93464
Address: Faculty of Sciences, Department of Biochemistry
MD, Emeritus Professor, Department of Physiology, University of Zürich
François Verrey is Professor Emeritus of Physiology at the University of Zurich. After high school in Zurich and medical school in Lausanne, he acted as ICRC delegate in Israel and resident in Internal Medicine at the CHUV. He then worked as postdoctoral fellow at the University of Lausanne, the ISREC and Columbia University, and started 1991 his own research group at the Institute of Physiology of the University of Zurich. He became Professor in 2001 and was director of the Institute from 2006-2014. He was vice-dean of the Faculty of Medicine, member of the research council of the SNSF and founder and director of the National Center of Competence in Research Kidney.CH until 2018. His research centered around epithelial transports in kidney and intestine, mainly regarding aldosterone-regulated sodium transport, and later transport and role of amino acids. Currently he is mainly engaged in the HSeT Foundation and as vice-director of the Swiss Kidney Foundation.
Address: Institute of Physiology, University of Zürich, Winterthurerstrasse 190, 8057 Zurich
MD PhD, Senior Lecturer, Faculty of Medicine and Health Sciences, University of Mauritius.
PhD was awarded in 2003. When the research centre became part of a newly created Department of Medicine of the Faculty of Science of the University of Mauritius in 2004, she was mostly involved in teaching of modules in the BSc (Hons) Medical Science programme, a pre-clinical programme of 3 years duration that been initiated in 1998, and which was run in partnership with two UK universities and subsequently with a French university. In 2011 she was involved as a link Coordinator in the setting up of a full-fledged undergraduate medical programme, the curricular contents of which were largely inspired from the programme run by the University of Geneva with which the University of Mauritius signed a memorandum of Understanding since 2013. She was mostly responsible for the setting up and the running of the first part of the programme as the Bachelor of Medicine Coordinator. Three cohorts registered in the undergraduate medical programme offered in English medium have been able to graduate so far, the first cohort has recently been able to successfully register with the Medical Council of Mauritius.
Attorney at Kellerhals Carrard Law Firm, Lausanne, Switzterland
Dr Frédéric Rochat was admitted as an attorney-at-law to the bars of the Canton of Vaud (2002) and New York (2005). He is a partner at the law firm of Carrard & Associés in Lausanne, Switzerland, specializing in corporate and contract law. In parallel he teaches law at various institutions.
Prior to joining Carrard & Associés in 2007, Frédéric earned his law degree in 1996 from the universities of Lausanne and Berne. While working as a teaching and research assistant in the fields of contract and securities law he obtained his doctorate from the University of Lausanne in 2002. He completed his two-year attorney traineeship and worked as an associate for one additional year in a business law firm in Lausanne, before leaving for the U.S. to obtain an LL.M. degree from Columbia University. From 2004 to 2007 he worked in the M& A and securities departments of the law firm of Simpson Thacher & Bartlett LLP in New York (2004-2005) and London (2006-2007).
PhD, Full professor, Department of Immunobiology, University of Lausanne
Sanjiv Luther, Sanjiv Luther studied cell biology at the ETH in Zürich. He received his PhD in 1996 from the University of Lausanne for his work on anti-viral immune responses in the Ludwig Institute for cancer research. Thereafter, he performed postdoctoral studies at the Howard Hughes Medical Institute of the University of California San Francisco, investigating the role of chemotactic factors in lymphoid tissue development and function. In 2003 he joined the Department of Immunobiology (formerly Biochemistry) as Assistant Professor funded by a career-development award from the Swiss National Science Foundation. In 2009 he became Associate Professor and in 2021 Full Professor. His longstanding research interest focuses on a better understanding of secondary lymphoid organs in immunity, particularly on the roles played by the resident fibroblastic stromal cells. Since 2003 he teaches bachelor, master and PhD students at UNIL, particularly in topics of immunology, using traditional lectures, exercises and practical work. Since 2009 he directs the biomedical master specialization in ‘immunology and cancer’, and in collaboration with HSeT introduced various elements of e-learning into the teaching curriculum.
+41 21 692 5678
MD, Emeritus Professor of Pharmacology, University of Lausanne
Bernard Rossier is MD, emeritus professor, former director of the Department of Pharmacology and Toxicology and former Dean of the Faculty of Biology and Medicine of the University of Lausanne. For more than thirty years, he led a research group working in the field of hypertension and he is the author of more than 200 publications in this field. He is the recipient of numerous international awards in the field of nephrology and hypertension. He is a member of EMBO, Academia Europaea, Deutsche Akademie der Naturforscher Leopoldina and the Swiss Academy of Medical Sciences. He is an Honorary Foreign Fellow of the American Academy of Arts and Sciences. He is Dr. honoris causa from the Pierre et Marie Curie University in Paris. He is co-founder of HSeT, member of the board and project coordinator in the field of pharmacology, toxicology and nephrology.
Phone: +41 21 692 58 60
Address: HSeT Foundation
c/o Center of Immunity and Infection (CIIL)
Chemin des Boveresses 155
CH-1066 Epalinges, Switzerland